.svg){kind=small}
Aug-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
West Coast Cure is stocked at 348 licensed dispensaries across California and Maine, 347 of them in California, with the deepest coverage in Los Angeles, Long Beach, Santa Ana, Costa Mesa, and Fresno. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
West Coast Cure’s mix in August 2026 is anchored by Vapor Pens at 48.22% share with a month-over-month lift of 0.52% despite a year-over-year decline of 9.19%, while Pre-Roll holds 20.33% share with a 5.44% MoM increase against a 20.40% YoY drop. Concentrates account for 16.34% share with a 3.35% MoM gain and a comparatively mild 1.93% YoY decline, as Flower slides to 13.92% share with a 32.93% MoM contraction and a 50.84% YoY fall. Edible remains a small 1.19% share but grew 6.27% MoM while declining 29.25% YoY. The overall profile implies a pivot away from Flower toward inhalables, with stability concentrated in Vapor Pens and Concentrates, which helps explain the brand’s August 2026 average price of $18.84 alongside a 7.02% YoY price decrease and a Vapor Pens rank of 13 in California.
The combination of a 32.93% MoM and 50.84% YoY contraction in Flower alongside a 0.52% MoM uptick in Vapor Pens and a 3.35% MoM gain in Concentrates indicates a deliberate emphasis on higher-velocity inhalables over bulk Flower. With Pre-Roll growing 5.44% MoM but shrinking 20.40% YoY, near-term share defense is occurring in impulse formats while longer-cycle declines persist in commoditized segments; this mix aligns with maintaining a mid-pack Vapor Pens position at rank 13 in California and suggests pricing room to trade shoppers into cartridges and extracts as the brand manages a 20.33% total YoY sales contraction and a 7.02% YoY average price reduction.
Competitive Landscape
West Coast Cure ranks #13 in CA Vapor Pens in August 2026, improving 2 positions from #15 year over year and slipping 1 position from #12 since May 2026; this sits 4 spots below its peak rank of #9 from August 2024 and 12 spots behind category leader STIIIZY at #1. Competitive movement at the top tightened: Jetty Extracts climbed from #4 to #3 with 40.6% YoY sales growth while Plug Play fell from #3 to #4 with a 14.1% YoY decline, indicating share is rotating among leaders even as Raw Garden held steady at #2 with a flat 0.2% YoY. The pattern—modest YoY rank improvement (+2) but short-term slippage (-1 since May 2026) alongside a widening gap to the top cluster—implies West Coast Cure is stabilizing mid-pack but must capture incremental share to avoid drifting further from the top 10.
Notable Products
CUREpen - Skywalker OG Distillate Cartridge (1g) posted the steepest shift in August 2026 with a -15.4% month-over-month decline while holding rank 2, contrasting with CUREpen - MK Ultra Distillate Oil Cartridge (1g) up 23.4% at rank 7; this divergence implies volatility within the flagship Vapor Pens lineup rather than a category-wide drop. Across the top ten, Vapor Pens occupy ranks 2 through 5 and 7 through 10 (eight of the top ten), with mixed movements from -10.6% to +23.4%, while Pre-Rolls bookend at rank 1 up 12.0% and at rank 6 with a new entry; the category concentration suggests reliance on pens for scale and Pre-Rolls for traffic. CUREjoint - Strawberry Banana Pre-Roll (1g) leads at rank 1 with +12.0% MoM and $24,927 in sales, whereas CUREpen - Northern Lights Distillate Cartridge (1g) slid -10.6% at rank 8, pointing to flavor-level reallocation within pens toward faster-growing strains. The pattern indicates West Coast Cure is leaning into a pen-heavy portfolio while selectively elevating Pre-Rolls to capture share at the very top, signaling a barbell strategy between a broad Vapor Pens core and a headline Pre-Roll winner.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
